Rituximab in the treatment of diffuse large B-Cell lymphomas

被引：41
|
作者：
Coiffier, B
机构：
[1] Hospices Civils Lyon, Lyon, France
[2] Univ Lyon 1, F-69365 Lyon, France
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 01期
关键词：
D O I：
10.1053/sonc.2002.30153
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：30 / 35
页数：6
相关论文
共 50 条
  • [41] Pathway activation patterns in diffuse large B-cell lymphomas
    S Bentink
    S Wessendorf
    C Schwaenen
    M Rosolowski
    W Klapper
    A Rosenwald
    G Ott
    A H Banham
    H Berger
    A C Feller
    M-L Hansmann
    D Hasenclever
    M Hummel
    D Lenze
    P Möller
    B Stuerzenhofecker
    M Loeffler
    L Truemper
    H Stein
    R Siebert
    R Spang
    Leukemia, 2008, 22 : 1746 - 1754
  • [42] Management of Elderly Patients with Diffuse Large B-Cell Lymphomas
    Ciancia, Rosanna
    Tirelli, Umberto
    Ribera, Josep-Maria
    Spina, Michele
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2013, 13 (09) : 1412 - 1418
  • [43] VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly
    Fina, Mariapaola
    Tani, Monica
    Stefoni, Vittorio
    Musuraca, Gerardo
    Marchi, Enrica
    Pellegrini, Cinzia
    Alinari, Lapo
    Derenzini, Enrico
    Bacci, Francesco
    Pileri, Stefano
    Baccarani, Michele
    Zinzani, Pier Luigi
    LEUKEMIA & LYMPHOMA, 2007, 48 (11) : 2167 - 2171
  • [44] Micro-classifying diffuse large B-cell lymphomas
    Tam, Wayne
    BLOOD, 2009, 113 (26) : 6506 - 6507
  • [45] Pathway activation patterns in diffuse large B-cell lymphomas
    Bentink, S.
    Wessendorf, S.
    Schwaenen, C.
    Rosolowski, M.
    Klapper, W.
    Rosenwald, A.
    Ott, G.
    Banham, A. H.
    Berger, H.
    Feller, A. C.
    Hansmann, M-L
    Hasenclever, D.
    Hummel, M.
    Lenze, D.
    Moeller, P.
    Stuerzenhofecker, B.
    Loeffler, M.
    Truemper, L.
    Stein, H.
    Siebert, R.
    Spang, R.
    LEUKEMIA, 2008, 22 (09) : 1746 - 1754
  • [46] TRANSFORMATION OF INDOLENT LYMPHOMAS INTO DIFFUSE LARGE B-CELL LYMPHOMA
    Magomedova, A. U.
    Kovrigina, A. M.
    Mangasarova, Y. K.
    Kravchenko, S. K.
    Nikulina, E. E.
    Obukhova, T. N.
    Zvonkov, E. E.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2024, 69 (01): : 112 - 120
  • [47] Prognostication of diffuse large B-cell lymphoma in the rituximab era
    Ninan, Mary J.
    Wadhwa, Punit D.
    Gupta, Pankaj
    LEUKEMIA & LYMPHOMA, 2011, 52 (03) : 360 - 373
  • [48] Incidence and survival of ocular diffuse large B-cell lymphomas
    Farrall, Alexandra L.
    Smith, Justine R.
    ACTA OPHTHALMOLOGICA, 2023, 101 (03) : E353 - E354
  • [49] The expanding role of rituximab and radioimmunotherapy in the treatment of B-cell lymphomas
    Jacobs, Samuel A.
    Foon, Kenneth A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (11) : 1749 - 1762
  • [50] PHARMACOKINETICS OF RITUXIMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Rozman, S.
    Grabnar, I.
    Novakovic, S.
    Mrhar, A.
    Novakovic, B. Jezersek
    HAEMATOLOGICA, 2017, 102 : 688 - 688
12345